The clinical value of the delta finger to palm distance in systemic sclerosis
- PMID: 32292020
- DOI: 10.4081/reumatismo.2020.1233
The clinical value of the delta finger to palm distance in systemic sclerosis
Abstract
Systemic sclerosis (SSc) is a collagen-vascular disorder characterized by fibrosis and vasculopathy. Delta finger to palm distance (delta FTP) is an index measuring the distance between the tip of the third finger to the distal palmar crease in the flexed and extended position. The present study aimed to evaluate the clinical value of delta FTP and to assess the correlation of delta FTP with modified Rodnan skin score (mRSS) and forced vital capacity (FVC) over the 12-month follow-up. This prospective longitudinal study began with 50 participants who were followed for twelve months. Lowess smoothing and linear regression were applied to detect and assess the relationship between delta FTP and mRSS. p-values were adjusted by the Benjamini-Hochberg method (BHM) as a control for false discovery rate. Delta FTP was lower among patients with higher disease duration (p-valueadj: 0.008), diffuse cutaneous SSc (p-valueadj: 0.006), digital ulcers (p-valueadj: 0.003), telangiectasia (p-valueadj: 0.006) and dysphagia (p-valueadj: 0.036). The mRSS has a significant negative linear effect on the delta FTP at the baseline and the end of the follow-up (r: -0.31 and -0.40, respectively). Moreover, changes of mRSS and delta FTP showed a negative linear association over time (r: -0.22). These linear effects remained significant after regrouping the patients based on their SSc subtype. Delta FTP and FVC were not correlated either at the baseline or at the end. It seems that the delta FTP can be a valuable clinical index, supported by its correlated changes with mRSS and other SSc clinical manifestations over the one-year follow-up.
Similar articles
-
Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis.Clin Exp Rheumatol. 2010 Mar-Apr;28(2 Suppl 58):S28-36. Epub 2010 Jun 10. Clin Exp Rheumatol. 2010. PMID: 20576211 Free PMC article.
-
Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort.J Dermatol. 2024 Oct;51(10):1290-1297. doi: 10.1111/1346-8138.17403. Epub 2024 Sep 5. J Dermatol. 2024. PMID: 39235167 Free PMC article.
-
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis.Arthritis Res Ther. 2025 Apr 11;27(1):85. doi: 10.1186/s13075-025-03508-9. Arthritis Res Ther. 2025. PMID: 40217251 Free PMC article.
-
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.Arthritis Rheumatol. 2018 Nov;70(11):1829-1834. doi: 10.1002/art.40557. Epub 2018 Sep 24. Arthritis Rheumatol. 2018. PMID: 29781588
-
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.Autoimmun Rev. 2015 Nov;14(11):1072-8. doi: 10.1016/j.autrev.2015.07.008. Epub 2015 Jul 22. Autoimmun Rev. 2015. PMID: 26209905 Review.
Cited by
-
Assessment of disease outcome measures in systemic sclerosis.Nat Rev Rheumatol. 2022 Sep;18(9):527-541. doi: 10.1038/s41584-022-00803-6. Epub 2022 Jul 20. Nat Rev Rheumatol. 2022. PMID: 35859133 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical